$PPCH ~ MELBOURNE, Australia, May 21, 2014 (GLOBE
Post# of 8672
Posted On: 05/22/2014 9:07:27 AM
$PPCH ~ MELBOURNE, Australia, May 21, 2014 (GLOBE NEWSWIRE) -- Propanc Health Group Corporation (PPCH) ("Propanc Health Group", "Propanc" or "the Company"
, a developmental stage healthcare company focused on new cancer treatments for patients with solid tumors, announced requests for information regarding the anti-cancer effects of its pancreatic proenzymes treatment ("PRP" , can be accessed via Cellular Oncology, a peer reviewed journal of the International Society for Cellular Oncology.
http://finance.yahoo.com/news/propanc-scienti...26082.html
, a developmental stage healthcare company focused on new cancer treatments for patients with solid tumors, announced requests for information regarding the anti-cancer effects of its pancreatic proenzymes treatment ("PRP" , can be accessed via Cellular Oncology, a peer reviewed journal of the International Society for Cellular Oncology. http://finance.yahoo.com/news/propanc-scienti...26082.html
(0)
(0)Scroll down for more posts ▼